World's Best Scientists 2026 revealed!
Kurt A. Schalper

Kurt A. Schalper

D-Index & Metrics

Biology and Biochemistry

D-Index
71
Citations
24400
World Ranking
6531
National Ranking
3042

Kurt A. Schalper publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Kurt A. Schalper sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 568 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Kurt A. Schalper D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kurt A. Schalper sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Kurt A. Schalper is affiliated with Yale University in the United States. Their research predominantly spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, and Cancer Research. This broad expertise supports scholarship in cancer immunotherapy and biomarkers as well as immunotherapy and immune responses.

Their main research topics include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Lung Cancer Treatments and Mutations
  • Immune cells in cancer
  • Cancer Genomics and Diagnostics
  • Lung Cancer Research Studies
  • Single-cell and spatial transcriptomics

Schalper has contributed to multiple scientific publications, notably in venues such as:

  • Cancer Research
  • Journal for ImmunoTherapy of Cancer
  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Regular and Young Investigator Award Abstracts

Recent significant publications by Schalper include:

  • "Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors" (2020) in Nature Medicine
  • "PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer" (2022) in New England Journal of Medicine
  • "CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity" (2020) in Immunity
  • "Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial" (2020) in The Lancet Oncology
  • "Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels" (2022) in JAMA Oncology

The scientist frequently collaborates with peers in the field, including:

  • Roy S. Herbst
  • David L. Rimm
  • Jonathan W. Riess
  • Sarah B. Goldberg
  • Vamsidhar Velcheti

Best Publications

  • Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

    Hira Rizvi;Francisco Sanchez-Vega;Konnor La;Walid Chatila

  • Programmed death ligand-1 expression in non-small cell lung cancer.

    Vamsidhar Velcheti;Kurt A Schalper;Daniel E Carvajal;Valsamo K Anagnostou

  • Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

    Jun Wang;Miguel F. Sanmamed;Ila Datar;Tina Tianjiao Su

  • Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.

    Joseph McLaughlin;Gang Han;Kurt A. Schalper;Daniel Carvajal-Hausdorf

  • Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade

    Ziming Wang;Ethan G. Aguilar;Jesus I. Luna;Cordelia Dunai

  • Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

    Scott Gettinger;Jungmin Choi;Katherine Hastings;Anna Truini

  • CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.

    Álvaro Teijeira;Saray Garasa;María Gato;Carlos Alfaro

  • Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes.

    Deborah B. Doroshow;Miguel F. Sanmamed;Katherine Hastings;Katerina Politi

  • Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis

    Steve Lu;Julie E. Stein;David L. Rimm;Daphne W. Wang

  • Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma.

    Kurt A. Schalper;Maria E. Rodriguez-Ruiz;Ricardo Diez-Valle;Alvaro López-Janeiro

  • Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors.

    Kurt A. Schalper;Michael Carleton;Ming Zhou;Tian Chen

  • In situ Tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas.

    Kurt A. Schalper;Vamsidhar Velcheti;Daniel Carvajal;Hallie Wimberly

  • Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.

    Sarah B Goldberg;Kurt A Schalper;Scott N Gettinger;Amit Mahajan

  • Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer

    Kurt A. Schalper;Jason Brown;Daniel Carvajal-Hausdorf;Joseph McLaughlin

  • Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.

    M. F. Sanmamed;J. L. Perez-Gracia;K. A. Schalper;J. P. Fusco

  • PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer

    Hallie Wimberly;Jason R. Brown;Kurt A Schalper;Herbert Haack

  • Interleukin-8 in cancer pathogenesis, treatment and follow-up.

    Carlos Alfaro;Miguel F. Sanmamed;María E. Rodríguez-Ruiz;Álvaro Teijeira

  • Oncolytic virus immunotherapy: future prospects for oncology

    Junaid Raja;Johannes M. Ludwig;Johannes M. Ludwig;Scott N. Gettinger;Kurt A. Schalper

  • Modulation of Brain Hemichannels and Gap Junction Channels by Pro-Inflammatory Agents and Their Possible Role in Neurodegeneration

    Juan A. Orellana;Pablo J. Sáez;Kenji F. Shoji;Kurt A. Schalper

  • Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

    Ila J Datar;Ila J Datar;Miguel F Sanmamed;Miguel F Sanmamed;Jun Wang;Brian S Henick;Brian S Henick

Frequent Co-Authors

David L. Rimm
David L. Rimm Yale University
Roy S. Herbst
Roy S. Herbst Yale University
Scott N. Gettinger
Scott N. Gettinger Yale University
Lieping Chen
Lieping Chen Yale University
Ignacio Melero
Ignacio Melero University of Oxford
Juan C. Sáez
Juan C. Sáez University of Valparaíso
Anant Madabhushi
Anant Madabhushi Emory University
Lajos Pusztai
Lajos Pusztai Yale University
Katerina Politi
Katerina Politi Yale University
Harriet M. Kluger
Harriet M. Kluger Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing studies in Biology and Biochemistry opens doors to a variety of dynamic career paths, many of which can be accessed or enhanced through flexible online degrees. Fields like medical coding and health information management are rapidly growing, in part due to the demand for skilled professionals who understand both science and technology. For those interested in this career, medical.coding salary trends show competitive compensation and career stability.

The healthcare sector continues to need qualified staff, making questions such as is medical billing and coding in demand highly relevant. Online learning options, such as health information management online programs, offer flexibility for those balancing studies, work, or family commitments.

Additionally, students with a foundation in biochemistry often consider advancing their knowledge through nutrition studies. Enrolling in an online nutrition masters program is a practical option, equipping graduates with expertise to succeed in both healthcare and wellness industries.

Best Scientists Citing Kurt A. Schalper

Trending Scientists

Recently Published Articles